Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis.
Bearzi P, Trunfio F, Coppola R, Currado D, Conforti C, Zanframundo S, Nibid L, Donati M, Panasiti V, Navarini L, Giacomelli R. Bearzi P, et al. Among authors: panasiti v. Dermatol Pract Concept. 2023 Jul 1;13(3):e2023183. doi: 10.5826/dpc.1303a183. Dermatol Pract Concept. 2023. PMID: 37557149 Free PMC article. No abstract available.
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.
Gori N, Sernicola A, Tolino E, Mariano M, Galluzzo M, Moretta G, Coppola R, D'Alessio A, Sansone M, Maffei V, Paolino C, Ferrao C, Cascia L, Addio P, Di Nardo L, Chiricozzi A, Del Duca E, Cristaudo A, Bianchi L, Pallotta S, Panasiti V, Pellacani G, Potenza C, Peris K. Gori N, et al. Among authors: panasiti v. J Dermatolog Treat. 2023 Dec;34(1):2230685. doi: 10.1080/09546634.2023.2230685. J Dermatolog Treat. 2023. PMID: 37400981 Free article.
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors.
Medri M, Savoia F, Foca F, Miserocchi A, Quaglino P, Rubatto M, Gullo G, Nardini C, Panasiti V, DE Tursi M, DI Marino P, Brancaccio G, Giunta EF, Napolitano S, Cinotti E, Brusasco M, Stanganelli I; IMI, Italian Melanoma Intergroup. Medri M, et al. Among authors: panasiti v. Ital J Dermatol Venerol. 2023 Dec;158(6):437-444. doi: 10.23736/S2784-8671.23.07542-4. Ital J Dermatol Venerol. 2023. PMID: 38015482 Free article.
Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region.
Dattola A, Bernardini N, Caldarola G, Coppola R, De Simone C, Giordano D, Giunta A, Moretta G, Pagnanelli G, Panasiti V, Persechino S, Potenza C, Trovato F, Zangrilli A, Bianchi L, Pellacani G, Peris K, Richetta AG. Dattola A, et al. Among authors: panasiti v. Dermatol Pract Concept. 2024 Jul 1;14(3):e2024166. doi: 10.5826/dpc.1403a166. Dermatol Pract Concept. 2024. PMID: 39122514 Free PMC article.
Melanoma and immunotherapy: the experience of Sapienza University of Rome.
Bottoni U, Clerico R, Richetta AG, Panasiti V, Corsetti P, Roberti V, Paolino G, Moliterni E, Grassi S, Calvieri S. Bottoni U, et al. Among authors: panasiti v. Ital J Dermatol Venerol. 2023 Feb;158(1):1-3. doi: 10.23736/S2784-8671.23.07424-8. Ital J Dermatol Venerol. 2023. PMID: 36939498 Free article. No abstract available.
Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld Dermoscopy.
Borroni RG, Panasiti V, Valenti M, Gargiulo L, Perrone G, Dall'Alba R, Fava C, Sacrini F, Mancini LL, Manara SAAM, Morenghi E, Costanzo A. Borroni RG, et al. Among authors: panasiti v. Cancers (Basel). 2023 Feb 10;15(4):1129. doi: 10.3390/cancers15041129. Cancers (Basel). 2023. PMID: 36831472 Free PMC article.
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.
Caldarola G, Zangrilli A, Bernardini N, Bavetta M, De Simone C, Graceffa D, Bonifati C, Faleri S, Giordano D, Mariani M, Micheli A, Moretta G, Pagnanelli G, Panasiti V, Provini A, Richetta A, Peris K, Bianchi L. Caldarola G, et al. Among authors: panasiti v. Dermatol Ther. 2022 Jun;35(6):e15489. doi: 10.1111/dth.15489. Epub 2022 Apr 13. Dermatol Ther. 2022. PMID: 35385202 Free PMC article.
Basal cell carcinoma arising within port-wine stain.
Marangi GF, Segreto F, Alessandri-Bonetti M, Coscarella G, Panasiti V, Vaienti L, Persichetti P. Marangi GF, et al. Among authors: panasiti v. Int J Dermatol. 2022 Jul;61(7):e269-e270. doi: 10.1111/ijd.15944. Epub 2021 Oct 10. Int J Dermatol. 2022. PMID: 34628637 No abstract available.
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.
Zangrilli A, Caldarola G, Bernardini N, Bavetta M, Graceffa D, Bonifati C, Cantoresi F, Faleri S, Giordano D, Mariani M, Micheli A, Moretta G, Pirro F, Pagnanelli G, Panasiti V, Provini A, Richetta A, Sacchelli L, Bianchi L, Peris K. Zangrilli A, et al. Among authors: panasiti v. Expert Opin Biol Ther. 2021 Sep;21(9):1291-1298. doi: 10.1080/14712598.2021.1948530. Epub 2021 Jul 18. Expert Opin Biol Ther. 2021. PMID: 34278889
63 results